99-16265. Manufacturer of Controlled Substances; Registration  

  • [Federal Register Volume 64, Number 123 (Monday, June 28, 1999)]
    [Notices]
    [Page 34682]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-16265]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Registration
    
        By Notice dated February 5, 1999, and published in the Federal 
    Register on February 26, 1999, (64 FR 9542), Novartis Pharmaceuticals 
    Corp., 59 Route 10, East Hanoever, New Jersey 07936, made application 
    by renewal to the Drug Enforcement Administration (DEA) to be 
    registered as a bulk manufacturer of methylphenidate (1724), a basic 
    class of controlled substance listed in Schedule II.
        The firm plans to manufacture finished product for distribution to 
    its customers.
        DEA has considered the factors in Title 21, United States Code, 
    Section 823(a) and determined that the registration of Novartis 
    Pharmaceuticals Corp. to manufacture methylphenidate is consistent with 
    the public interest at this time. DEA has investigated Novartis 
    Pharmaceuticals Corp. on a regular basis to ensure that the company's 
    continued registration is consistent with the public interest. These 
    investigations have included inspection and testing of the company's 
    physical security systems, audits of the company's records, 
    verification of the company's compliance with state and local laws, and 
    a review of the company's background and history. Therefore, pursuant 
    to 21 U.S.C. 823 and 28 CFR sections 0.100 and 0.104, the Deputy 
    Assistant Administrator, Office of Diversion Control, hereby orders 
    that the application submitted by the above firm for registration as a 
    bulk manufacturer of the basic class of controlled substance listed 
    above is granted.
    
        Dated: June 15, 1999.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 99-16265 Filed 6-25-99; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
06/28/1999
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
99-16265
Pages:
34682-34682 (1 pages)
PDF File:
99-16265.pdf